Integrated Biology and Testing Services Briefly
WuXi AppTec's Biology and Testing capabilities support pharmaceutical and biotech companies worldwide with integrated services spanning discovery biology, preclinical development, and clinical testing.
Multidisciplinary teams collaborate across biology, DMPK, bioanalysis, and safety assessment to support programs from early discovery through key development milestones. Our scientific expertise and flexible platforms support small molecules, biologics, and advanced therapeutic modalities.
Explore Our Capabilities
-
Discovery Biology
From target identification and hit finding to in vitro assay development, in vivo pharmacology, and lead optimization.
-
Drug Metabolism and Pharmacokinetics (DMPK)
Comprehensive in vitro and in vivo ADME, pharmacokinetics, and metabolite identification services.
-
Bioanalysis and Clinical Testing
Method development and validation, biomarker testing, and central laboratory support across drug development.
-
Safety Assessment
Toxicology and pathology services supporting programs from early safety evaluation through IND-enabling development and beyond.
-
Flexible Solutions for Your Development Needs
Our cross-disciplinary teams work across chemistry, biology, DMPK, toxicology, and bioanalysis to address scientific challenges. Flexible engagement models range from standalone studies to integrated discovery collaborations, supported by global infrastructure and established scientific platforms.
Stay Connected
Keep up with the latest news and insights.
